Metiapine

This classification denotes an antipsychotic agent with the molecular formula C19H21N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 775D6D91J8, chemically known as 2-methyl-11-(4-methyl-1-piperazinyl)dibenzo(b,f)(1,4)thiazepine but generally known as metiapine, which bears US NIH Compound Identifier 22047. European Medicines Agency schedules Metiapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08882MIG. The term METIAPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). METIAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metiapine under HS 29349990 and SITC 51579. As of Q4 2014, METIAPINE remains the US FDA Preferred Term for this commodity. Metiapine bears US NLM identifiers UMLS ID C0066451 and NCI Concept Code C90761. SMILES: S1C2C(C(=NC3C1CCCC3)N1CCN(CC1)C)CC(CC2)C.